Strategic Pharmaceutical Partnership for Global Expansion Through WHO-GMP Manufacturing Excellence
The pharmaceutical industry continues to evolve rapidly, creating unprecedented opportunities for companies seeking expansion into emerging and high-growth markets. Across Asia and Africa, healthcare demand is increasing at a remarkable pace, driven by population growth, improved healthcare infrastructure, government initiatives, and rising awareness of quality medicines. In this dynamic environment, successful market expansion requires more than just a product portfolio—it demands a reliable manufacturing partner with proven regulatory expertise, scalable production capabilities, and comprehensive export support.
As a leading pharmaceutical manufacturer operating from a WHO-GMP, GLP, and RCMC certified facility, we offer strategic partnerships designed to help pharmaceutical companies accelerate their growth across international markets. Through our specialized capabilities in Third-Party Manufacturing and Merchant Export Services, we provide a complete platform for organizations seeking sustainable expansion and long-term competitive advantage.
Why Strategic Pharmaceutical Partnerships Are Essential for Global Growth
Global pharmaceutical markets have become increasingly competitive. Companies aiming to establish or strengthen their presence in Africa, Asia, the Middle East, Latin America, and CIS countries face numerous challenges, including:
- Regulatory compliance requirements
- Product registration complexities
- Supply chain management
- Product sourcing challenges
- Market-specific documentation requirements
- Quality assurance expectations
- Competitive pricing pressures
A strategic partnership with an experienced pharmaceutical manufacturer eliminates many of these obstacles. By leveraging established infrastructure, regulatory resources, and manufacturing expertise, companies can significantly reduce market entry timelines and optimize operational efficiency.
Our commitment is to provide a comprehensive partnership model that supports every stage of international business development.
WHO-GMP, GLP, and RCMC Certified Manufacturing Excellence
Quality remains the foundation of pharmaceutical success. Our manufacturing facility located in the Sarigam Industrial Zone, Vapi-Daman Region, India, operates under stringent international quality standards.
Our certifications include:
- WHO-GMP Certification
- GLP Compliance
- RCMC Registration
- International quality management systems
- Robust quality assurance protocols
- Advanced production infrastructure
These certifications demonstrate our commitment to maintaining consistent product quality, regulatory compliance, and manufacturing excellence across all production activities.
Every formulation is developed and manufactured using validated processes, ensuring compliance with international regulatory requirements and customer expectations.
REGULATORY STATUS & DOSSIER AVAILABILITY
| Product Name | Strength | Pharmacopoeial Standard | Pharmaceutical Form | Available Dossiers |
|---|---|---|---|---|
| Azithromycin | 500 mg | BP | Tablet | CTD + ACTD |
| Azithromycin | 250 mg | BP | Tablet | CTD + ACTD |
| Itraconazole | 200 mg | BP | Capsule | CTD + ACTD |
| Sildenafil Citrate | 100 mg | BP | Tablet | CTD + ACTD |
| Tramadol Hydrochloride | 100 mg | USP | Tablet | CTD |
| Sildenafil Citrate | 50 mg | USP | Tablet | CTD |
| Tadalafil | 20 mg | BP | Tablet | CTD |
| Tadalafil | 10 mg | USP | Tablet | CTD |
| Levocetirizine Dihydrochloride | 5 mg | USP | Tablet | CTD |
| Levocetirizine Dihydrochloride + Montelukast | 5 mg + 10 mg | USP / BP | Tablet | CTD |
| Albendazole | 400 mg | USP | Tablet | CTD |
| Rosuvastatin | 20 mg | BP | Tablet | CTD |
| Paracetamol + Acetylsalicylic Acid + Caffeine | 500 mg + 250 mg + 65 mg | USP / BP / BP | Tablet | CTD |
| Paracetamol | 500 mg | BP | Tablet | CTD |
| Paracetamol + Propyphenazone + Caffeine | 250 mg + 150 mg + 50 mg | USP / BP / BP | Tablet | CTD |
| Tramadol Hydrochloride | 50 mg | USP | Tablet | CTD |
| Flupirtine Maleate | 100 mg | In-house | Capsule | CTD |
| Propranolol Hydrochloride | 20 mg | BP | Tablet | CTD |
| Thiamine Hydrochloride | 100 mg | USP | Tablet | CTD |
TAJ PHARMA – PRODUCTS LIST (TABLETS / CAPSULES / CREAMS)
| Product Name | Brand Name | Therapeutic Category | Dosage Form | Available Strengths | BCS Class (Estimate) |
|---|---|---|---|---|---|
| Azithromycin | Azitaj | Macrolide Antibiotic | Tablet | 250 mg, 500 mg | Class III |
| Itraconazole | Itrataj | Antifungal | Capsule | 200 mg | Class II |
| Sildenafil Citrate | Sildataj | Erectile Dysfunction Therapy | Tablet | 50 mg, 100 mg | Class II |
| Tramadol Hydrochloride | Tramataj | Analgesic / Pain Management | Tablet | 50 mg, 100 mg | Class I |
| Tadalafil | Tadataj | Erectile Dysfunction Therapy | Tablet | 10 mg, 20 mg | Class II |
| Levocetirizine Dihydrochloride | Levotaj | Antihistamine / Anti-Allergic | Tablet | 5 mg | Class III |
| Levocetirizine Dihydrochloride + Montelukast Sodium | Levomont-Taj | Anti-Allergic / Anti-Asthmatic | Tablet | 5 mg + 10 mg | Class III |
| Albendazole | Albetaj | Anthelmintic | Tablet | 400 mg | Class II |
| Rosuvastatin Calcium | Rosutaj | Antihyperlipidemic | Tablet | 20 mg | Class II |
| Paracetamol + Acetylsalicylic Acid + Caffeine | Analgetaj Plus | Analgesic / Antipyretic | Tablet | 500 mg + 250 mg + 65 mg | N/A |
| Paracetamol | Parataj | Analgesic / Antipyretic | Tablet | 500 mg | Class I |
| Paracetamol + Propyphenazone + Caffeine | Analgetaj Forte | Analgesic / Pain Relief | Tablet | 250 mg + 150 mg + 50 mg | N/A |
| Flupirtine Maleate | Flupitaj | Non-Opioid Analgesic | Capsule | 100 mg | Class II |
| Propranolol Hydrochloride | Proprataj | Beta Blocker / Antihypertensive | Tablet | 20 mg | Class I |
| Thiamine Hydrochloride (Vitamin B1) | Thiamtaj | Vitamin Supplement | Tablet | 100 mg | Class III |
| Product Name | Brand Name | Therapeutic Category | Dosage Form | Available Strengths | BCS Class (Estimate) |
|---|---|---|---|---|---|
| Aminophylline | Aminotaj | Bronchodilator / Anti-Asthmatic | Tablet | 100 mg | Class III |
| Amitriptyline Hydrochloride | Amitaj | Antidepressant | Tablet | 25 mg | Class I |
| Amoxicillin | Amoxtaj | Antibiotic (Penicillin) | Dispersible Tablet | 250 mg, 500 mg | Class I |
| Artemether + Lumefantrine | Artemtaj-L | Antimalarial | Tablet | 20 mg + 120 mg | Class IV |
| Atenolol | Atenotaj | Antihypertensive (Beta Blocker) | Tablet | 50 mg, 100 mg | Class III |
| Carbamazepine | Carbataj | Antiepileptic | Tablet | 200 mg | Class II |
| Chloroquine Base | Chlorotaj | Antimalarial | Tablet | 150 mg | Class I |
| Cloxacillin | Cloxtaj | Antibiotic (Penicillin) | Capsule | 250 mg, 500 mg | Class III |
| Diazepam | Diaztaj | Anxiolytic / Sedative | Tablet | 5 mg | Class I |
| Digoxin | Digitaj | Cardiac Glycoside | Tablet | 250 mcg | Class I |
| Doxycycline | Doxytaj | Antibiotic (Tetracycline) | Tablet | 100 mg | Class I |
| Ferrous Sulfate | Ferrotaj | Hematinic | Tablet | 60 mg | Class III |
| Fluoxetine | Fluotaj | Antidepressant (SSRI) | Capsule | 20 mg | Class I |
| Furosemide | Furotaj | Diuretic | Tablet | 40 mg | Class IV |
| Glibenclamide | Glibetaj | Antidiabetic | Tablet | 5 mg | Class II |
| Haloperidol | Halotaj | Antipsychotic | Tablet | 5 mg | Class I |
| Hydrochlorothiazide | Hydrotaj | Diuretic / Antihypertensive | Tablet | 25 mg | Class IV |
| Isosorbide Dinitrate | Isotaj | Antianginal | Sublingual Tablet | 5 mg | Class I |
| Mebendazole | Mebetaj | Anthelmintic | Chewable Tablet | 100 mg | Class IV |
| Metformin Hydrochloride | Mettaj | Antidiabetic | Tablet | 500 mg | Class III |
| Methyldopa | Methytaj | Antihypertensive | Tablet | 250 mg | Class III |
| Metronidazole | Metrotaj | Antiprotozoal / Antibacterial | Tablet | 250 mg, 500 mg | Class I |
| Misoprostol | Misotaj | Obstetrics & Gynecology | Tablet | 200 mcg | Class I |
| Multi-Micronutrients | Nutritaj | Nutritional Supplement | Capsule | As per formula | N/A |
| Nifedipine IR | Nifetaj | Antihypertensive | Tablet | 10 mg | Class II |
| Nitrofurantoin | Nitrotaj | Urinary Anti-Infective | Tablet | 100 mg | Class IV |
| Nystatin | Nystataj | Antifungal | Tablet | 500,000 IU | Class IV |
| Phenobarbital | Phenotaj | Antiepileptic / Sedative | Tablet | 15 mg, 100 mg | Class I |
| Phenoxymethyl Penicillin (Penicillin V) | Penvitaj | Antibiotic | Tablet | 250 mg, 500 mg | Class I |
| Primaquine Base | Primataj | Antimalarial | Tablet | 7.5 mg | Class I |
| Retinol (Vitamin A) | Vitataj-A | Vitamin Supplement | Soft Gel Capsule | 200,000 IU | Class II |
| Salbutamol | Salbutaj | Bronchodilator | Tablet | 4 mg | Class I |
| Sulfamethoxazole + Trimethoprim | Cotritaj | Antibacterial | Tablet | 400 mg + 80 mg | Class I |
| Sulfamethoxazole + Trimethoprim | Cotritaj-DS | Antibacterial | Dispersible Tablet | 100 mg + 20 mg | Class I |
| Acetylsalicylic Acid (Aspirin) | Aspitaj | Antiplatelet / Analgesic | Tablet | 100 mg, 500 mg | Class I |
| Activated Charcoal | Charcotaj | Antidote / Adsorbent | Tablet | 500 mg | N/A |
| Aluminium Hydroxide + Magnesium Hydroxide | Antacitaj | Antacid | Chewable Tablet | 200 mg + 200 mg | N/A |
| Calcium | Calcitaj | Mineral Supplement | Tablet | 1 g | Class III |
| Chlorpheniramine Maleate | Chlorotaj | Antihistamine | Tablet | 4 mg | Class I |
| Ciprofloxacin | Ciprotaj | Antibiotic (Fluoroquinolone) | Tablet | 250 mg | Class III |
| Ergometrine Maleate | Ergotaj | Uterotonic | Tablet | 0.2 mg | Class I |
| Famotidine | Famotaj | Antiulcer | Tablet | 40 mg | Class III |
| Ferrous Sulfate + Folic Acid | Ferrofol-Taj | Hematinic | Tablet | 60 mg + 400 mcg | N/A |
| Folic Acid | Folitaj | Vitamin Supplement | Tablet | 5 mg | Class III |
| Ibuprofen | Ibutaj | NSAID | Tablet | 200 mg | Class II |
| Metoclopramide Hydrochloride | Metotaj | Antiemetic | Tablet | 10 mg | Class III |
| Nystatin Vaginal | Nystataj-V | Antifungal | Vaginal Tablet | 100,000 IU | Class IV |
| Paracetamol | Parataj | Analgesic / Antipyretic | Tablet | 100 mg, 500 mg | Class I |
| Zinc Dispersible | Zinctaj | Nutritional Supplement | Dispersible Tablet | 20 mg | Class III |
TAJ PHARMA – TOPICAL CREAMS / OINTMENTS / GELS
| Product Name | Brand Name | Therapeutic Category | Dosage Form | Available Strengths | BCS Class (Estimate) |
|---|---|---|---|---|---|
| Betamethasone + Neomycin | Betaneotaj | Corticosteroid + Antibiotic | Cream | 0.1% + 0.5% | N/A |
| Chlorhexidine Digluconate Gel | Chlorotaj Gel | Antiseptic | Gel | 7.1% | N/A |
| Lidocaine Gel | Lidotaj | Local Anesthetic | Gel | 2%, 4% | N/A |
| Silver Sulfadiazine | Silvertaj | Burn Management | Cream | 1% | N/A |
| Tetracycline Eye Ointment | Tetrataj Eye | Ophthalmic Antibiotic | Eye Ointment | 1% | N/A |
| Zinc Oxide | Zinctaj Cream | Skin Protectant | Cream | 20% | N/A |
TAJ PHARMA – ORAL LIQUIDS / SUSPENSIONS
| Product Name | Brand Name | Therapeutic Category | Dosage Form | Available Strengths | BCS Class (Estimate) |
|---|---|---|---|---|---|
| Amoxicillin | Amoxtaj Dry Syrup | Antibiotic | Powder for Suspension | 125 mg/5 ml, 250 mg/5 ml | Class I |
| Chloroquine | Chlorotaj Syrup | Antimalarial | Syrup | 50 mg/5 ml | Class I |
| Erythromycin | Erythrotaj | Antibiotic | Dry Syrup | 125 mg/5 ml | Class I |
| Ferrous Sulfate | Ferrotaj Syrup | Hematinic | Oral Solution | 125 mg/5 ml | Class III |
| Ciprofloxacin | Ciprotaj Suspension | Antibiotic | Oral Suspension | 250 mg/5 ml | Class III |
| Metronidazole | Metrotaj Suspension | Antiprotozoal | Suspension | 200 mg/5 ml | Class I |
| Nystatin | Nystataj Suspension | Antifungal | Oral Suspension | 100,000 IU/ml | Class IV |
| Paracetamol | Parataj Syrup | Analgesic / Antipyretic | Syrup | 120 mg/5 ml | Class I |
| Salbutamol | Salbutaj Syrup | Bronchodilator | Syrup | 2 mg/5 ml | Class I |
| Sulfamethoxazole + Trimethoprim | Cotritaj Suspension | Antibacterial | Oral Suspension | 200 mg + 40 mg/5 ml | Class I |
| Aluminium Hydroxide + Magnesium Hydroxide | Antacitaj Suspension | Antacid | Suspension | 225 mg + 200 mg/5 ml | N/A |
Comprehensive Third-Party Pharmaceutical Manufacturing Solutions
Third-party manufacturing has emerged as one of the most effective business models for pharmaceutical companies seeking rapid expansion without substantial capital investment.
Our third-party manufacturing services offer:
Cost-Efficient Production
Companies can eliminate the need for large investments in manufacturing facilities, equipment, validation processes, and workforce management.
Scalable Manufacturing Capacity
We provide flexible production capabilities that accommodate:
- Small pilot batches
- Commercial-scale production
- Large-volume export requirements
- Market-specific product customization
Regulatory Compliance Assurance
All manufacturing operations follow internationally accepted quality systems, reducing compliance risks and supporting seamless product registrations.
Private Label and Contract Manufacturing
We offer customized solutions including:
- Brand-specific manufacturing
- Custom packaging
- Country-specific labeling
- Product customization
- Regulatory document support
This allows our partners to focus on marketing, distribution, and market expansion while we manage the complexities of pharmaceutical production.
Merchant Export Services Designed for Global Success
Merchant exports continue to play a critical role in international pharmaceutical trade. Through our specialized merchant export division, we support pharmaceutical importers, distributors, government tenders, NGOs, and healthcare organizations worldwide.
Our merchant export services include:
- Product sourcing
- Export documentation
- Regulatory support
- Logistics coordination
- Customs compliance
- Packaging adaptation
- Market-specific labeling
This comprehensive approach simplifies international procurement while ensuring timely product delivery and regulatory conformity.
Accelerate Registrations with 190 CTD Dossiers
One of the most significant challenges in international pharmaceutical expansion is the product registration process.
To address this challenge, we provide access to 190 Common Technical Document (CTD) dossiers covering both pharmaceutical and nutraceutical products.
These dossiers offer substantial advantages:
Faster Market Entry
Regulatory submissions can be initiated more quickly, reducing approval timelines.
Reduced Development Costs
Partners benefit from ready-to-use documentation, eliminating the need for costly dossier preparation from scratch.
Regulatory Confidence
Professionally prepared CTD dossiers support smoother interactions with health authorities and regulatory agencies.
Broader Product Opportunities
A diverse dossier portfolio allows partners to select products aligned with local market demands and therapeutic priorities.
This extensive regulatory resource represents a valuable asset for companies seeking immediate growth opportunities.
Access to 1019 COPPs for International Registrations
Certificates of Pharmaceutical Product (COPPs) remain essential for many international registration procedures.
Our portfolio includes access to 1019 COPPs, supporting pharmaceutical registrations across numerous global markets.
Key benefits include:
- Simplified registration processes
- Faster documentation availability
- Enhanced regulatory acceptance
- Improved market access opportunities
- Reduced administrative burdens
By providing comprehensive regulatory support, we help partners navigate complex approval pathways with greater efficiency and confidence.
350+ Approved Formulations Across Major Therapeutic Segments
Product portfolio strength is a critical factor in achieving sustainable pharmaceutical growth.
We offer more than 350 approved pharmaceutical formulations, covering a wide range of therapeutic categories.
Our portfolio includes:
Cardiovascular Products
Cardiovascular diseases continue to represent one of the largest therapeutic markets globally.
Our cardiovascular portfolio includes formulations designed to address:
- Hypertension
- Heart failure
- Dyslipidemia
- Antiplatelet therapy
- Anticoagulation management
- Cardiac support therapies
Neuropsychiatry Products
Mental health and neurological disorders are receiving increasing healthcare attention worldwide.
Our neuropsychiatry portfolio includes therapies targeting:
- Anxiety disorders
- Depression
- Schizophrenia
- Bipolar disorder
- Neuropathic conditions
- Epilepsy management
Additional Therapeutic Categories
Beyond cardiovascular and neuropsychiatry expertise, we offer products across multiple healthcare segments, including:
- Anti-infectives
- Gastrointestinal medicines
- Respiratory therapies
- Analgesics
- Anti-diabetics
- Nutraceuticals
- Vitamins and minerals
- Women’s healthcare
- Pediatric formulations
This diverse portfolio enables partners to build comprehensive market offerings while addressing evolving healthcare needs.
Comprehensive Regulatory and Documentation Support
Successful pharmaceutical exports require extensive documentation and regulatory compliance.
Our regulatory support services include:
- CTD dossier availability
- COPP documentation
- Product specifications
- Certificates of Analysis
- Stability data support
- Manufacturing licenses
- GMP certifications
- Product registration assistance
These resources help reduce regulatory complexity and facilitate successful market approvals.
End-to-End Marketing Support for International Partners
A successful market launch extends beyond manufacturing.
To support our partners’ commercial success, we provide:
Professional Visual Aids
High-quality promotional materials designed to support product positioning and healthcare professional engagement.
Labeling and Packaging Support
Country-specific:
- Labels
- Cartons
- Product inserts
- Artwork development
Product Samples
Cost-effective sample support enables distributors and marketing teams to evaluate products before large-scale procurement.
Brand Development Assistance
We collaborate with partners to ensure products are professionally presented and aligned with local market expectations.
This integrated support model strengthens market entry efforts and enhances commercial outcomes.
Why Asian and African Markets Represent Significant Growth Opportunities
Asia and Africa remain among the fastest-growing pharmaceutical markets globally.
Several factors continue to drive demand:
- Expanding populations
- Urbanization
- Improved healthcare access
- Government healthcare initiatives
- Growing middle-class populations
- Increased chronic disease prevalence
- Rising pharmaceutical consumption
Companies entering these markets with quality-assured products and strong regulatory support can establish substantial competitive advantages.
Our strategic partnership model is specifically designed to help businesses capitalize on these emerging opportunities while minimizing operational risks.
Building Long-Term Pharmaceutical Success Through Collaboration
The future of pharmaceutical growth lies in strategic collaboration, operational excellence, and regulatory readiness. Companies that align with experienced manufacturing partners gain access to valuable resources, accelerated market entry pathways, and scalable growth opportunities.
With a WHO-GMP, GLP, and RCMC certified manufacturing facility, access to 190 CTD dossiers, 1019 COPPs, and a portfolio of 350+ approved formulations, we provide a complete platform for international pharmaceutical expansion.
Whether your objective is third-party manufacturing, merchant exports, private labeling, or international product registrations, our comprehensive solutions are designed to support sustainable growth across Asia, Africa, and other emerging markets.
By combining manufacturing excellence, regulatory expertise, and commercial support, we help transform pharmaceutical opportunities into long-term business success.






